New melasma cream may offer same results with fewer side effects
NCT ID NCT05119413
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new cream for melasma, a skin condition causing dark patches. The new cream uses thiamidol instead of hydroquinone, which often causes side effects. 40 adults with melasma tried either the new cream or the standard treatment to see if it works as well but is gentler on the skin.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nice
Nice, Alpes-maritimes, 06200, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.